PROPAIRA NAD 100 (Propaira Pty Ltd)
Product Name
PROPAIRA NAD 100
Sponsor
ARTG details
433072
Date of review outcome
Date of publication
Mar-2026
Outcome
Medicine is no longer permitted to be supplied
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, use of this medicine may pose a safety risk for some people. Follow the recommended actions below.
What action should consumers take?
Seek advice from a health professional if you have been taking this medicine to prevent the development of chronic cardiovascular, neurodegenerative, and metabolic diseases.
Consider whether this medicine is right for you given that claims including to replenish NAD, boost cellular NAD+ levels, maintain optimal levels of NAD+, increase the healthy lifespan, live younger for longer, and repair DNA damage were not substantiated by the sponsor.
Be aware this medicine does not contain the ingredient NAD as implied by its name and advertising.
Consider whether this medicine is right for you given that claims including to replenish NAD, boost cellular NAD+ levels, maintain optimal levels of NAD+, increase the healthy lifespan, live younger for longer, and repair DNA damage were not substantiated by the sponsor.
Be aware this medicine does not contain the ingredient NAD as implied by its name and advertising.
Review scope
Targeted (see Additional Information below)
Information reviewed
ARTG Record, Labels, Manufacturing Documentation, Website
Issues related to safety
The website for this medicine implies it can help prevent the development of chronic cardiovascular, neurodegenerative, and metabolic diseases. Chronic cardiovascular, neurodegenerative, and metabolic diseases can be serious conditions that require diagnosis, treatment or supervision by a suitably qualified health professional. Reference to these conditions is not permitted for listed medicines or without prior evaluation and approval from the TGA.
The label and advertisement for this medicine contained claims outlined in 'What action should consumers take?' above. These claims are not permitted for listed medicines without prior evaluation or approval from the TGA.
References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitably qualified health professional, which may result in adverse outcomes.
While claims of this nature are unacceptable, the sponsor cancelled this medicine, and removed the advertisements for this medicine, therefore it is unlikely to pose an immediate risk to consumer health and safety.
The label and advertisement for this medicine contained claims outlined in 'What action should consumers take?' above. These claims are not permitted for listed medicines without prior evaluation or approval from the TGA.
References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitably qualified health professional, which may result in adverse outcomes.
While claims of this nature are unacceptable, the sponsor cancelled this medicine, and removed the advertisements for this medicine, therefore it is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
This medicine does not contain the ingredient NAD as implied by its name. Therefore, it may not work for claims related to NAD.
The website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
The website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
Actions taken during the review
The TGA required the sponsor to correct the issues with this medicine. The sponsor cancelled this medicine and withdrew it from further supply.
Additional information
This medicine was targeted to check its compliance in relation to claims about nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN)